Investigation into the role of DUB3/USP17 in Ras signalling
Investigation into the role of DUB3/USP17 in Ras signalling
批准号:
BB/F013647/1
负责人:
Christopher Scott
金额:
$41.32万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have uncovered a novel regulatory mechanism for the control of the Ras pathway, a major cell signalling pathway that is involved in the control of cell proliferation and survival. Specifically, we have shown that a novel enzyme (DUB-3), that we first reported to have a major impact on cell proliferation, achieves this via its action on Ras Converting Enzyme 1 (RCE1). In order for Ras to be activated properly, it undergoes a number of post-translational modifications, one of which is performed by RCE1. Previously it has been assumed that RCE1 is active upon its production by the cell. We have now shown that this simplistic view of the protease is inaccurate and that its activity is controlled by DUB-3. We have shown in a number of cell types that RCE1 is 'labelled' by the addition of ubiquitin. The addition of ubiquitin to proteins has many different effects, depending on the nature of the target protein and the specific nature of the ubiquitin linkage. These effects include labelling of the target protein for degradation, activation, inactivation or re-localisation within the cell. In the specific case of RCE1, our data has shown that removal of ubiquitin by DUB-3 inhibits the activity of RCE1 and therefore blunts its ability to process Ras. Our results also suggest that the action of DUB-3 is specific, in that other deubiquitinating enzymes cannot regulate RCE1 and that DUB-3 action upon proliferation is RCE1 dependant. Despite this insight, these exciting results highlight many questions which require further investigation. In this proposal we aim to evaluate DUB-3 and its relationship with RCE1. At this time we do not understand the type of ubiquitin linkage present on RCE1 and how this promotes or maintain its activity. Here we have presented a number of experiments that will rapidly uncover the molecular basis of this control by DUB-3. Furthermore, using microscopy analysis of cells we will visualise how RCE1 localisation is affected in the presence of DUB-3. Finally, others have shown that Ras is not the only protein that can be modified by RCE1. In fact, a number of key cell signalling protein families contain the same motif that is present in Ras and recognised and clipped by RCE1. Therefore, we will examine the effect of DUB-3 on these other pathways, aiming to gain insight into the undoubtedly complicated interplay that exists at the molecular level controlling proteins with varying roles that are all processed by RCE1.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/s12964-018-0291-5
发表时间:
2018-11-08
期刊:
Cell communication and signaling : CCS
影响因子:
--
作者:
[McCann AP, Smyth P, Cogo F, McDaid WJ, Jiang L, Lin J, Evergren E, Burden RE, Van Schaeybroeck S, Scott CJ, Burrows JF]
通讯作者:
Burrows JF
DOI:
10.15252/embr.202051932
发表时间:
2022-04-05
期刊:
EMBO reports
影响因子:
7.7
作者:
[Lin J, McCann AP, Sereesongsaeng N, Burden JM, Alsa'd AA, Burden RE, Micu I, Williams R, Van Schaeybroeck S, Evergren E, Mullan P, Simpson JC, Scott CJ, Burrows JF]
通讯作者:
Burrows JF
DOI:
10.18632/oncotarget.2165
发表时间:
2014-08-30
期刊:
Oncotarget
影响因子:
--
作者:
[Jaworski J, de la Vega M, Fletcher SJ, McFarlane C, Greene MK, Smyth AW, Van Schaeybroeck S, Johnston JA, Scott CJ, Rappoport JZ, Burrows JF]
通讯作者:
Burrows JF
Development of a Chemoproteomics Centre of Excellence: A Prosperity Partnership for Drug Discovery in Northern Ireland
-
批准号:BB/Y00325X/1
-
项目类别:Research Grant
-
资助金额:$335.05万
-
财政年份:2023
-
负责人:Christopher Scott
-
依托单位:
DRivers and Impacts of Ionospheric Variability with EISCAT-3D (DRIIVE)
-
批准号:NE/W003384/1
-
项目类别:Research Grant
-
资助金额:$3.27万
-
财政年份:2022
-
负责人:Christopher Scott
-
依托单位:
Development of intracellular VNARs as novel tools to dissect intracellular biological processes
-
批准号:BB/R009112/1
-
项目类别:Research Grant
-
资助金额:$44.16万
-
财政年份:2018
-
负责人:Christopher Scott
-
依托单位:
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
-
批准号:MC_PC_15013
-
项目类别:Intramural
-
资助金额:$19.11万
-
财政年份:2015
-
负责人:Christopher Scott
-
依托单位:
Driving space weather forecasts with real data
-
批准号:NE/J024678/1
-
项目类别:Research Grant
-
资助金额:$35.66万
-
财政年份:2012
-
负责人:Christopher Scott
-
依托单位:
Development of a novel anti-inflammatory nanoparticle for the treatment of Acute Lung Injury
-
批准号:MR/J014680/1
-
项目类别:Research Grant
-
资助金额:$67.67万
-
财政年份:2012
-
负责人:Christopher Scott
-
依托单位:
Pan-American Studies Institute (PASI): Adaptive Water-Energy Management in the Arid Americas; La Serena, Chile, 2013
-
批准号:1242209
-
项目类别:Standard Grant
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:Christopher Scott
-
依托单位:
Evaluation of antibody targeted controlled release nanoparticle systems
-
批准号:G1001805/1
-
项目类别:Fellowship
-
资助金额:$5.79万
-
财政年份:2011
-
负责人:Christopher Scott
-
依托单位:
CNH: Strengthening Resilience of Arid Region Riparian Corridors: Ecohydrology and Decision Making in the Sonora and San Pedro Watersheds
-
批准号:1010495
-
项目类别:Standard Grant
-
资助金额:$140.0万
-
财政年份:2010
-
负责人:Christopher Scott
-
依托单位:
Molecular and pharmacological validation of Cathepsin S as a novel target in cancer treatment
-
批准号:G0901615/1
-
项目类别:Research Grant
-
资助金额:$46.6万
-
财政年份:2010
-
负责人:Christopher Scott
-
依托单位:
Workforce Training for Stem Cell Research
-
批准号:0920799
-
项目类别:Standard Grant
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Christopher Scott
-
依托单位:
Mechanisms of negative feedback regulation of GnRH by testosterone in males
-
批准号:nhmrc : 124352
-
项目类别:NHMRC Project Grants
-
资助金额:$16.23万
-
财政年份:2000
-
负责人:Christopher Scott
-
依托单位:
Oestrogen action in the brain in relation to the regulation of gonadotrophin releasing hormone
-
批准号:nhmrc : 967147
-
项目类别:Early Career Fellowships
-
资助金额:$14.75万
-
财政年份:1996
-
负责人:Christopher Scott
-
依托单位:
海外基金